Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice
Varsha Kumar, … , Reinhold E. Schmidt, J. Engelbert Gessner
Varsha Kumar, … , Reinhold E. Schmidt, J. Engelbert Gessner
Published February 1, 2006
Citation Information: J Clin Invest. 2006;116(2):512-520. https://doi.org/10.1172/JCI25536.
View: Text | PDF
Research Article Immunology

Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice

  • Text
  • PDF
Abstract

Complement C5a, a potent anaphylatoxin, is a candidate target molecule for the treatment of inflammatory diseases, such as myocardial ischemia/reperfusion injury, RA, and the antiphospholipid syndrome. In contrast, up until now, no specific contribution of C5a and its receptor, C5aR, was recognized in diseases of antibody-dependent type II autoimmunity. Here we identify C5a as a novel key mediator of autoimmune hemolytic anemia (AIHA) and show that mice lacking C5aR are partially resistant to this IgG autoantibody–induced disease model. Upon administration of anti-erythrocyte antibodies, upregulation of activating Fcγ receptors (FcγRs) on Kupffer cells, as observed in WT mice, was absent in C5aR-deficient mice, and FcγR-mediated in vivo erythrophagocytosis was impaired. Surprisingly, in mice deficient in FcγRI and FcγRIII, anti-erythrocyte antibody–induced C5 and C5a production was abolished, demonstrating the existence of a previously unidentified FcγR-mediated C5a-generating pathway. These results show that the development of a full-blown antibody-dependent autoimmune disease requires C5a — produced by and acting on FcγR — and may suggest therapeutic benefits of C5 and/or C5a/C5aR blockade in AIHA and other diseases closely related to type II autoimmune injury.

Authors

Varsha Kumar, Syed R. Ali, Stephanie Konrad, Jörg Zwirner, J. Sjef Verbeek, Reinhold E. Schmidt, J. Engelbert Gessner

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Reduced Kupffer cell–mediated rbc destruction in FcγRI/III–/– and C5aR–/...
Reduced Kupffer cell–mediated rbc destruction in FcγRI/III–/– and C5aR–/– mice during 34-3C mAb–induced AIHA. (A) WT C57BL/6 (open circles), FcγRI/III–/– (filled circles), and C5aR–/– (filled squares) mice injected with 300 μg of anti-rbc 34-3C mAb were analyzed for Kupffer cell–mediated in vivo phagocytosis at the indicated times. Results are shown as the percentage of Mac-1–selected Kupffer cells containing more than 2 ingested rbcs ± SD obtained from 4–9 mice in each group. (B) H&E-stained liver sections obtained from the indicated mice at days 0 and 2 after AIHA induction were analyzed for erythrophagocytosis by light microscopy. Shown is the mean cell count ± SEM of rbc-containing liver cells per microscopic field (original magnifications, ×40 and ×100) obtained from 3–5 mice in each group. (A and B) Significant differences were determined by Student’s t test (*P < 0.05; **P < 0.001).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts